Is it safe?
Can RGEN take a bad year?
Repligen Corporation holds $259M more cash than debt, so a bad year is a question about profits, not about lenders.
$259M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Interest cover
- 2.92×
Interest cover · operating profit covers the interest bill, with room to spare
- Annualised volatility
- 49%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtQ2 2026
- $551M
- Cash and short-term investments
- $810M
- Net cash
- $259M
- EBITDA, trailing twelve months
- $124M
- Operating profit, trailing twelve months
- $65M
- Debt / equity
- 0.26×
- Total debt / EBITDA
- 4.45×
- Annualised volatilitytwo years of daily moves
- 49%
- Worst drawdown on file
- −68%
- Below its 52-week high
- −0.84%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Instruments & Supplies
Ranks #11 of 27 by Smart Score